Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Killock

Showing results (141-150 of 304) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|January 30, 2023
Early MRD predicts disease recurrence and benefit from adjuvant chemotherapy in CRCDavid Killock
Nature Reviews. Clinical Oncology|March 12, 2025
Reduced-volume radiotherapy for locally advanced NPC improves QOL without compromising efficacyDavid Killock
Nature Reviews. Clinical Oncology|December 24, 2014
Haematological cancer: ASPIRE for unprecedented benefit with carfilzomib in MMDavid Killock
Nature Reviews. Clinical Oncology|September 3, 2014
Immunotherapy: the treatment bug--fighting cancer with bacterial infectionDavid Killock
Nature Reviews. Clinical Oncology|January 1, 2016
Haematological cancer: Ibrutinib paves way to a brighter future in MCLDavid Killock
Nature Reviews. Clinical Oncology|April 20, 2016
Brain cancer: Chemoradiotherapy for low-grade glioma: battle won, but the war goes onDavid Killock
Nature Reviews. Clinical Oncology|April 7, 2020
PSMA PET-CT improves stagingDavid Killock
Nature Reviews. Clinical Oncology|June 18, 2024
Isatuximab-VRd quadruplet shows promise in transplant-ineligible NDMMDavid Killock
Nature Reviews. Clinical Oncology|August 10, 2023
Novel ICI-TKI combination improves HCC outcomesDavid Killock
Nature Reviews. Clinical Oncology|May 31, 2022
New CAPSTONE of SCLC therapy?David Killock
Pageof 31

Showing results (141-150 of 304) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|January 30, 2023
Early MRD predicts disease recurrence and benefit from adjuvant chemotherapy in CRCDavid Killock
Nature Reviews. Clinical Oncology|March 12, 2025
Reduced-volume radiotherapy for locally advanced NPC improves QOL without compromising efficacyDavid Killock
Nature Reviews. Clinical Oncology|December 24, 2014
Haematological cancer: ASPIRE for unprecedented benefit with carfilzomib in MMDavid Killock
Nature Reviews. Clinical Oncology|September 3, 2014
Immunotherapy: the treatment bug--fighting cancer with bacterial infectionDavid Killock
Nature Reviews. Clinical Oncology|January 1, 2016
Haematological cancer: Ibrutinib paves way to a brighter future in MCLDavid Killock
Nature Reviews. Clinical Oncology|April 20, 2016
Brain cancer: Chemoradiotherapy for low-grade glioma: battle won, but the war goes onDavid Killock
Nature Reviews. Clinical Oncology|April 7, 2020
PSMA PET-CT improves stagingDavid Killock
Nature Reviews. Clinical Oncology|June 18, 2024
Isatuximab-VRd quadruplet shows promise in transplant-ineligible NDMMDavid Killock
Nature Reviews. Clinical Oncology|August 10, 2023
Novel ICI-TKI combination improves HCC outcomesDavid Killock
Nature Reviews. Clinical Oncology|May 31, 2022
New CAPSTONE of SCLC therapy?David Killock
Pageof 31